ICOTYDE

ICOTROKINRA · Janssen Biotech, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ICOTYDE, covering 2026-03-17 to 2026-07-24. Get the full timeline:

Most recent: First oral medicine targeting interleukin-23 receptor recommended for plaque psoriasis